The Future of Gastric Cancer Treatment: CLDN18.2 Targeted Therapy & Solid Tumor CAR-T
Zolbetuximab price drops nearly 30% at Jiahui. Satri-cel (CT041), the world's first solid tumor CAR-T, nears approval. Both targeting CLDN18.2 — now available at Jiahui International Cancer Center.
Read More →
IVF Center Expands with New State-of-the-Art Embryology Lab
Our Reproductive Medicine Center opens a new embryology laboratory equipped with time-lapse incubators and advanced genetic testing capabilities.
Read More →
From Palliative Care to a Second Chance at Life: A Pakistani Patient's CAR-T Journey to China
Read how Muhammad came to Jiahui after relapsing post-transplant, and found hope through CAR-T therapy — a story of cross-border care, compassion, and healing.
Read More →
Doctor Spotlight: Li Jun, MD — Leading Surgical Oncologist
Meet Dr. Li Jun, whose expertise in hepatobiliary surgery has attracted patients from over 15 countries to Jiahui.
Read More →
Jiahui Receives JCI Re-Accreditation with Full Marks
Jiahui International Hospital maintains its JCI accreditation, confirming our commitment to the highest international healthcare standards.
Read More →
International Patient Seminar: Navigating Healthcare in China
Jiahui hosted a seminar for the international community in Shanghai, covering insurance, visas, and cross-border care coordination.
Read More →